Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

With Prevnar Challenger Fully Funded, Affinivax Raises $120m For Other Novel Vaccines

Apr 23 2020

• By Mandy Jackson

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background — Affinivax is developing pneumococcal and other vaccines with its MAPS platform • Source: Shutterstock

Related Content

Pfizer’s 20-Valent Vaccine And Prevnar Successor Succeeds In Phase III

Mar 19 2020

Affinivax’s MAPS Vaccine Technology Reaches Clinic In Under Five Years

Feb 13 2019

Astellas Builds Vaccine Portfolio With Affinivax Pneumococcal Candidate

Feb 28 2017

Related Companies

Affinivax, Inc.

Pfizer Inc.

Astellas Pharma, Inc.

Additional Topics

Financing Vaccines Innovation StartUps and SMEs Companies Commercial Infectious Diseases BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window